jump to search | jump to navigation

News of the dayBlocking death messages from S. aureus can halt bone disease

07.09.10 Nottingham/Dublin – Irish researchers have identified a new target in S.aureus bacteria that cause progressive bone destruction. According to Tania Claro from Royal College of Surgeons, S. aureus makes use of its surface protein...more
 

Forbion to channel most of its new €190m fund into European life sciences firms

06.09.10 Naarden – Dutch life sciences venture capital investor Forbion Capital Partners has closed two funds, raising more than €190m ($240m). The company said it will invest EUR54m through 1st FCF I Co-Invest Fund into selected... more
 

Addex reports on new Alzheimer compound

03.09.10 Geneva - Allosteric modulation specialist Addex Pharmaceuticals Ltd has observed efficacy of its oral pre-clincal drug candidate mGluR2 NAM in a model of Alzheimer's disease. The allosteric compound specifically inhibits... more
 

Product of the WeekOne of the best - Huber are again awarded the TOP 100 seal for innovation!

06.09.10 Professor Dr. Nikolaus Franke holds the chair for entrepreneurship and innovation at the University of Economics in Vienna. There, the innovative behaviour of small and middle sized enterprises, from all branches of industry all...more
 
Metanavigation